Mohamed El-Sisi, Medical Oncology Senior Registrar at Hayat national hospital MADINAH branch – KSA, shared a post on LinkedIn:
“I am honored to participate in BGICC WITH MY E-POSTER about Herceptin biosimilar KANJINTI in treatment of HER2 positive breast cancer.”
